ACTIVE LAWSUIT!
NextWhat is a Civil Lawsuit?
Everything You Need to Know
Published by Free Confidential Lawsuit Review
If you or a loved one was injured, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm toll-free 24 hrs/day by dialing (866) 588-0600.
Table Of Contents
What is Eisai Co.?
Eisai Co., Ltd. is the Tokyo, Japan-based pharmaceutical corporation that oversaw Belviq manufacturing. Although Eisai Co. is headquartered in Japan, the company has locations all over the world. Eisai Inc. is based in the United States, with its medical research headquarters in Woodcliff Lake, New Jersey.
Additional Eisai Co. Ltd. locations inside the U.S. include research facilities in North Carolina, manufacturing sites in North Carolina and Maryland, and the Eisai Research Institute and the Genetics Guided Dementia Discovery Institute in Massachusetts.
Related Article: Belviq (Lorcaserin) Lawsuit Update
What Other Drugs Does Eisai Make?
In addition to Belviq, Eisai Co. Ltd. and its partners manufacture the following drugs:
- Fragmin – An anticoagulant drug used for the treatment of pulmonary embolism (PE) and deep vein thrombosis (DVT)
- Banzel – A seizure medication prescribed to treat Lennox-Gastaut Syndrome
- Halaven – Subcutaneous injection drug used to treat advanced breast cancer
- Gliadel – Medication wafer implanted into the brain after the tumor removal surgery
- Aloxi – A prescription drug used to prevent chemotherapy-induced nausea and vomiting
Is Belviq Back on the Market?
No. Belviq is no longer available in the United States after a 5-year post-marketing study found an increased risk of cancer associated with the drug. Eisai Inc. voluntarily recalled Belviq from the U.S. market in February 2020.
Related Article: Why Was Belviq Taken Off the Market?
How Did Eisai Respond to the Belviq Recall?
The CAMELLIA-TIMI 61 clinical trial discovered that 7.7% of Belviq patients developed cancer over the course of the 5-year study, while the placebo group developed cancer at a 7.1% rate. While the 0.6% difference may not seem exceptionally high, this statistic still highlights a disturbing trend. After looking at the research, the U.S. Food and Drug Administration asked Eisai, Inc. to voluntarily recall Belviq and Belviq XR.
However, Eisai, Inc. is continuing to defend itself from the FDA’s withdrawal judgment, despite complying with the Feb. 2020 recall. Eisai continues to assert that the potential benefits of the drugs outweigh the potential health risks and that the company’s interpretation of CAMELLIA-TIMI 61 differs from the FDA’s.
Related Article: What Cancers are Linked With Belviq?
Is There a Generic for Belviq?
In 2019, the Indian multinational pharmaceutical company Zydus Lifesciences Limited received a tentative nod from the FDA to market lorcaserin hydrochloride tablets in a dosage strength of 10 mg in the United States. The product is the generic of Eisai’s Belviq tablets, 10 mg.
FAQs
Can I join a lawsuit if I took Belviq and developed cancer?
Yes, individuals who took Belviq and developed cancer may be eligible to join a lawsuit. Consulting with a personal injury lawyer who specializes in pharmaceutical litigation can help determine eligibility and guide the legal process.
What compensation can be sought in a Belviq lawsuit?
Compensation in a Belviq lawsuit can include medical expenses, lost wages, pain and suffering, and punitive damages. These aim to cover the costs of cancer treatment and other related expenses, as well as compensate for the impact on the victim’s life.
How do I start a legal claim if I was affected by Belviq?
To start a legal claim if you were affected by Belviq, contact a lawyer experienced in pharmaceutical litigation. They will review your medical history, gather evidence, and file a claim on your behalf to seek compensation for your injuries.
Related Articles:
See all related dangerous drug litigation our attorneys have covered.
Get a Free Lawsuit Evaluation With Our Lawyers
The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers focusing on plaintiffs’ representation in lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one got cancer after taking Belviq, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.